Close Menu
    What's Hot

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    How Time Reveals the Secrets to Longevity

    Mortality September 14, 2022By Chris Eccles
    Longevity
    Share
    Twitter LinkedIn Email

    Many years ago, my 85-year-old mother and 90-year-old father were at dinner with my wife and I. When the meal was over, the time arrived to decide whether to have dessert. Mom looked down at her pudgy self and declared, as she had every night for the previous seven decades, that she needed to begin watching what she was eating in order to lose weight.

    As a professor of public health, you might expect my first reaction would have been to agree with her. Decades ago, yes, but at her age my reaction was the exact opposite. I said Mom, if carrying excess weight was a harmful risk factor for you – you’d be dead already. Go ahead and enjoy dessert, just not in excess. She did just that, with a sense of relief I might add.

    This paradox is an example of a public health phenomenon known as “selective survival”. That is, the passage of time uncovers subgroups of the population with unique attributes that enable them to live long. Selective survival is also the reason why some now suggest that Covid-19 culled the weaker and more frail members of humanity with pre-existing health conditions – leaving behind a more robust population that could yield a post-Covid life expectancy rebound.

    These unusual and often rare survivors are interesting because they’re somehow protected from a relentless and well-established lethal risk factor, such as smoking. The documented longest-lived person in history – Jeanne Calment from France – died in 1997 at the age of 122, and she smoked for more than a century.

    For the same reasons, this is also why many researchers in the field of aging like to study the genetics of centenarians – because time shines a spotlight on them as beacons of hope as researchers scramble to understand what’s different about these people, and whether it’s possible for science and medicine to discover and then find a way to confer their survival advantage on the rest of us.

    Jay Olshansky, Lapetus Solutions

    Consider a hypothetical experiment where we start out with 1 million babies born in a given year, and half of them are required to begin smoking by age 10 while the other half remain non-smokers throughout life. The average duration of life for the smokers would be many years shorter than the non-smokers. However, 100 years after this otherwise fateful experiment, time would reveal a small percentage of the original half million smokers still alive 90 years later, for whom smoking was never a risk factor to begin with.

    This is how selective survival operates. Ironically, this is also how evolution works. Differences in survival (and fertility) reveal population subgroups with different risk factors and survival prospects.

    Some people survive to extreme old age carrying with them a lifetime of behavioral risk factor baggage that tends to kill everyone else at a much earlier age. These folks smoke cigarettes, drink excessively, eat large amounts of fat; etc. Basically, everything your doctor and mother tell you that you shouldn’t be doing. Yet they survive anyway. This is the main reason why a generic approach to survival analysis where people with certain risk factors are all treated exactly the same – using a common mortality multiplier – will often lead to grossly incorrect estimates of survival. The bottom line is that people experiencing exceptional longevity often do not exhibit healthy lifestyles, which tells you there are other reasons why they live so long. Genetics!

    This brings me to a recent scientific discovery: “We may finally know why so many lifelong smokers never get lung cancer”. The secret is in their genes. There is a group of cells in our lungs known as bronchial epithelial cells that accumulate genetic damage every time they divide. These are the cells most likely to transform into cancer cells within the lungs and they’re the primary cells involved in lung cancer. The process of transforming bronchial epithelial cells into cancer cells is determined by the amount of abuse we exact on our lungs during the course of life (either on purpose or by accident), and the level of DNA repair that operates within those cells.

    In a study of exceptionally long-lived lifelong smokers compared with younger people – including both smokers and non-smokers; it was discovered that the long-term smokers that survived to extreme old age experienced genetic mutations that slowed considerably after about 23 years of tobacco abuse. That is, they had exceptionally powerful DNA repair mechanisms that were so effective, they eliminated or dramatically delayed the risk of lung cancer – even in the presence of decades of self-inflicted tobacco abuse.

    It is believed that these highly efficient DNA repair mechanisms are inherited, although some scientists suggest that highly efficient DNA repair can be an acquired trait – but researchers are still working out the details.

    Either way, we now think we know how some people can live so long after decades of inhaling toxic substances that kill the rest of the population at a much younger age. Although we’re nowhere near determining in advance, at younger ages, whether you’re a member of the population subgroup that has superman DNA repair in bronchial epithelial cells, that time might not be far off.

    S. Jay Olshansky, Ph.D. is Chief Scientist at Lapetus Solutions and Wealthspan Financial Partners and Professor of Public Health at the University of Illinois at Chicago


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2022 - September Commentary Longevity Risk Mortality Risk Volume 1 Issue 5 - September 2022
    Share. Twitter LinkedIn Email

    Related Posts

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026By LMI Newsdesk

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026By LMI Newsdesk

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026By LMI Newsdesk

    The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

    February 9, 2026By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.